Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer

被引：0
|
作者：
Seema Agarwal
Frank B Gertler
Michele Balsamo
John S Condeelis
Robert L Camp
Xiaonan Xue
Juan Lin
Thomas E Rohan
David L Rimm
机构：
[1] Yale University School of Medicine,Department of Pathology
[2] Massachusetts Institute of Technology,Department of Biology and Koch Institute for Integrative Cancer Research
[3] Albert Einstein College of Medicine,Department of Anatomy and Structural Biology, Gruss Lipper Biophotonics Center
[4] Albert Einstein College of Medicine,Department of Epidemiology and Population Health
来源：
Breast Cancer Research | / 14卷
关键词：
Breast Cancer; Benzoic Hydrazide; Index Array; Haven Hospital; Mouse Breast Cancer Model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] New prognostic marker in breast cancer
    Rashidi, Kaveh
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (06) : 528 - 528
  • [42] Maspin, a prognostic marker for breast cancer?
    Zhang, PJ
    Nolan, C
    Driscoll, DL
    Maggio, P
    Brooks, JJ
    LABORATORY INVESTIGATION, 1998, 78 (01) : 31A - 31A
  • [43] PIK3R1 underexpression is an independent prognostic marker in breast cancer
    Cizkova, Magdalena
    Vacher, Sophie
    Meseure, Didier
    Trassard, Martine
    Susini, Aurelie
    Mlcuchova, Dana
    Callens, Celine
    Rouleau, Etienne
    Spyratos, Frederique
    Lidereau, Rosette
    Bieche, Ivan
    BMC CANCER, 2013, 13
  • [44] EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
    Zehni, Alaleh Zati
    Jeschke, Udo
    Hester, Anna
    Kolben, Thomas
    Ditsch, Nina
    Jacob, Sven-Niclas
    Mumm, Jan-Niclas
    Heidegger, Helene Hildegard
    Mahner, Sven
    Vilsmaier, Theresa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 11
  • [45] PIK3R1 underexpression is an independent prognostic marker in breast cancer
    Magdalena Cizkova
    Sophie Vacher
    Didier Meseure
    Martine Trassard
    Aurélie Susini
    Dana Mlcuchova
    Celine Callens
    Etienne Rouleau
    Frederique Spyratos
    Rosette Lidereau
    Ivan Bièche
    BMC Cancer, 13
  • [46] UROKINASE-PLASMINOGEN ACTIVATOR, A NEW AND INDEPENDENT PROGNOSTIC MARKER IN BREAST-CANCER
    DUFFY, MJ
    REILLY, D
    OSULLIVAN, C
    OHIGGINS, N
    FENNELLY, JJ
    ANDREASEN, P
    CANCER RESEARCH, 1990, 50 (21) : 6827 - 6829
  • [47] Total circulating microRNA level as an independent prognostic marker for risk stratification in breast cancer
    Gahlawat, Aoife Ward
    Fahed, Lavinia
    Witte, Tania
    Schott, Sarah
    BRITISH JOURNAL OF CANCER, 2022, 127 (01) : 156 - 162
  • [48] DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer
    Germain, Devon R.
    Graham, Kathryn
    Glubrecht, Darryl D.
    Hugh, Judith C.
    Mackey, John R.
    Godbout, Roseline
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 53 - 63
  • [49] Total circulating microRNA level as an independent prognostic marker for risk stratification in breast cancer
    Aoife Ward Gahlawat
    Lavinia Fahed
    Tania Witte
    Sarah Schott
    British Journal of Cancer, 2022, 127 : 156 - 162
  • [50] Diminished Expression of MiR-15a Is an Independent Prognostic Marker for Breast Cancer Cases
    Shinden, Yoshiaki
    Akiyoshi, Sayuri
    Ueo, Hiroki
    Nambara, Syo
    Saito, Tomoko
    Komatsu, Hisateru
    Ueda, Masami
    Hirata, Hidenari
    Sakimura, Shotaro
    Uchi, Ryutaro
    Takano, Yuki
    Iguchi, Tomohiro
    Eguchi, Hidetoshi
    Sugimachi, Keishi
    Kijima, Yuko
    Ueo, Hiroaki
    Natsugoe, Shoji
    Mimori, Koshi
    ANTICANCER RESEARCH, 2015, 35 (01) : 123 - 127
12345